News Overview


Bernadett Bodo
A discovery & pre-clinical-stage company and a pioneer in the development of transformative pan-cancer therapies that target the tumor microenvironment removing barriers and inducing intra-tumoral immune architecture for effective full-circle immunotherapy. We focus on the discovery, design and engineering of catalytic immune effectors systems.

You may also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.